Director/PDMR Shareholding

RNS Number : 1273F

GlaxoSmithKline PLC

17 April 2014

 



 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

The Administrators of the GlaxoSmithKline 2009 Performance Share Plan (the Plan) notified the Company and the under-mentioned Directors and Persons Discharging Managerial Responsibility (PDMR) on 16 April 2014 of the following increases in their notional interests in Ordinary Shares at a price of 1581.50 pence per Ordinary Share and American Depositary Shares (ADSs) at a price of $52.55 per ADS following the notional re-investment of the dividend paid to shareholders on 10 April 2014.

Director/PDMR	Ordinary Shares	ADSs
Sir Andrew Witty	19,564.837
Dr M M Slaoui		5,637.905
Mr S Dingemans	8,217.586
Mr S M Bicknell	1,325.959
Mr R G Connor	2,687.452
Mrs D P Connelly		2,344.551
Mr J Ford		303.243
Mr S A Hussain	6,666.166
Mr W C Louv		1,653.860
Mr D S Redfern	2,829.821
Ms C Thomas	3,905.590
Mr P C Thomson	1,905.093
Mr D E Troy		3,350.705
Dr P J T Vallance	8,136.668
Ms E Walmsley	4,729.965
Mrs V A Whyte	541.530

The notional dividends accrued will be paid out in proportion to the percentage of participants' Plan holdings that vest following the end of the relevant measurement period.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

17 April 2014

 

END

 

 

RDSEDLFFZZFZBBK